img

Global Ruminant Vaccines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ruminant Vaccines Market Research Report 2024

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
According to Mr Accuracy reports’s new survey, global Ruminant Vaccines market is projected to reach US$ 3610.6 million in 2034, increasing from US$ 2441 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ruminant Vaccines market research.
Key manufacturers engaged in the Ruminant Vaccines industry include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ruminant Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ruminant Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ruminant Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other

Segment by Application


Cattle
Sheep
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ruminant Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Ruminant Vaccines Market Overview
1.1 Product Overview and Scope of Ruminant Vaccines
1.2 Ruminant Vaccines Segment by Type
1.2.1 Global Ruminant Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Ruminant Vaccines Segment by Application
1.3.1 Global Ruminant Vaccines Market Value by Application: (2024-2034)
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Other
1.4 Global Ruminant Vaccines Market Size Estimates and Forecasts
1.4.1 Global Ruminant Vaccines Revenue 2024-2034
1.4.2 Global Ruminant Vaccines Sales 2024-2034
1.4.3 Global Ruminant Vaccines Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Ruminant Vaccines Market Competition by Manufacturers
2.1 Global Ruminant Vaccines Sales Market Share by Manufacturers (2024-2024)
2.2 Global Ruminant Vaccines Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Ruminant Vaccines Average Price by Manufacturers (2024-2024)
2.4 Global Ruminant Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Ruminant Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ruminant Vaccines, Product Type & Application
2.7 Ruminant Vaccines Market Competitive Situation and Trends
2.7.1 Ruminant Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ruminant Vaccines Players Market Share by Revenue
2.7.3 Global Ruminant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ruminant Vaccines Retrospective Market Scenario by Region
3.1 Global Ruminant Vaccines Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Ruminant Vaccines Global Ruminant Vaccines Sales by Region: 2024-2034
3.2.1 Global Ruminant Vaccines Sales by Region: 2024-2024
3.2.2 Global Ruminant Vaccines Sales by Region: 2024-2034
3.3 Global Ruminant Vaccines Global Ruminant Vaccines Revenue by Region: 2024-2034
3.3.1 Global Ruminant Vaccines Revenue by Region: 2024-2024
3.3.2 Global Ruminant Vaccines Revenue by Region: 2024-2034
3.4 North America Ruminant Vaccines Market Facts & Figures by Country
3.4.1 North America Ruminant Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Ruminant Vaccines Sales by Country (2024-2034)
3.4.3 North America Ruminant Vaccines Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ruminant Vaccines Market Facts & Figures by Country
3.5.1 Europe Ruminant Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Ruminant Vaccines Sales by Country (2024-2034)
3.5.3 Europe Ruminant Vaccines Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ruminant Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Ruminant Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Ruminant Vaccines Sales by Country (2024-2034)
3.6.3 Asia Pacific Ruminant Vaccines Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ruminant Vaccines Market Facts & Figures by Country
3.7.1 Latin America Ruminant Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Ruminant Vaccines Sales by Country (2024-2034)
3.7.3 Latin America Ruminant Vaccines Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ruminant Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Ruminant Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Ruminant Vaccines Sales by Country (2024-2034)
3.8.3 Middle East and Africa Ruminant Vaccines Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ruminant Vaccines Sales by Type (2024-2034)
4.1.1 Global Ruminant Vaccines Sales by Type (2024-2024)
4.1.2 Global Ruminant Vaccines Sales by Type (2024-2034)
4.1.3 Global Ruminant Vaccines Sales Market Share by Type (2024-2034)
4.2 Global Ruminant Vaccines Revenue by Type (2024-2034)
4.2.1 Global Ruminant Vaccines Revenue by Type (2024-2024)
4.2.2 Global Ruminant Vaccines Revenue by Type (2024-2034)
4.2.3 Global Ruminant Vaccines Revenue Market Share by Type (2024-2034)
4.3 Global Ruminant Vaccines Price by Type (2024-2034)
5 Segment by Application
5.1 Global Ruminant Vaccines Sales by Application (2024-2034)
5.1.1 Global Ruminant Vaccines Sales by Application (2024-2024)
5.1.2 Global Ruminant Vaccines Sales by Application (2024-2034)
5.1.3 Global Ruminant Vaccines Sales Market Share by Application (2024-2034)
5.2 Global Ruminant Vaccines Revenue by Application (2024-2034)
5.2.1 Global Ruminant Vaccines Revenue by Application (2024-2024)
5.2.2 Global Ruminant Vaccines Revenue by Application (2024-2034)
5.2.3 Global Ruminant Vaccines Revenue Market Share by Application (2024-2034)
5.3 Global Ruminant Vaccines Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Ruminant Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Zoetis Ruminant Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Boehringer Ingelheim Ruminant Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Ceva Ruminant Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.5.4 CAHIC Ruminant Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.6.4 HVRI Ruminant Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Ringpu Biology Ruminant Vaccines Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Corporation Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Yebio Ruminant Vaccines Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.9.4 DHN Ruminant Vaccines Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.10.4 WINSUN Ruminant Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco
6.11.1 Elanco Corporation Information
6.11.2 Elanco Ruminant Vaccines Description and Business Overview
6.11.3 Elanco Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Elanco Ruminant Vaccines Product Portfolio
6.11.5 Elanco Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Corporation Information
6.12.2 Virbac Ruminant Vaccines Description and Business Overview
6.12.3 Virbac Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Virbac Ruminant Vaccines Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Corporation Information
6.13.2 Jinyu Bio-Technology Ruminant Vaccines Description and Business Overview
6.13.3 Jinyu Bio-Technology Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Jinyu Bio-Technology Ruminant Vaccines Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Ruminant Vaccines Description and Business Overview
6.14.3 ChengDu Tecbond Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.14.4 ChengDu Tecbond Ruminant Vaccines Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Ruminant Vaccines Description and Business Overview
6.15.3 CAVAC Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.15.4 CAVAC Ruminant Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken Laboratories
6.16.1 Kyoto Biken Laboratories Corporation Information
6.16.2 Kyoto Biken Laboratories Ruminant Vaccines Description and Business Overview
6.16.3 Kyoto Biken Laboratories Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Kyoto Biken Laboratories Ruminant Vaccines Product Portfolio
6.16.5 Kyoto Biken Laboratories Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Corporation Information
6.17.2 FATRO Ruminant Vaccines Description and Business Overview
6.17.3 FATRO Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.17.4 FATRO Ruminant Vaccines Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Corporation Information
6.18.2 Vaksindo Ruminant Vaccines Description and Business Overview
6.18.3 Vaksindo Ruminant Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Vaksindo Ruminant Vaccines Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ruminant Vaccines Industry Chain Analysis
7.2 Ruminant Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ruminant Vaccines Production Mode & Process
7.4 Ruminant Vaccines Sales and Marketing
7.4.1 Ruminant Vaccines Sales Channels
7.4.2 Ruminant Vaccines Distributors
7.5 Ruminant Vaccines Customers
8 Ruminant Vaccines Market Dynamics
8.1 Ruminant Vaccines Industry Trends
8.2 Ruminant Vaccines Market Drivers
8.3 Ruminant Vaccines Market Challenges
8.4 Ruminant Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ruminant Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ruminant Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ruminant Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ruminant Vaccines Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Ruminant Vaccines Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Ruminant Vaccines Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Ruminant Vaccines Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Ruminant Vaccines Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Ruminant Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Ruminant Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ruminant Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Ruminant Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ruminant Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ruminant Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ruminant Vaccines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Ruminant Vaccines Sales by Region (2024-2024) & (K Units)
Table 18. Global Ruminant Vaccines Sales Market Share by Region (2024-2024)
Table 19. Global Ruminant Vaccines Sales by Region (2024-2034) & (K Units)
Table 20. Global Ruminant Vaccines Sales Market Share by Region (2024-2034)
Table 21. Global Ruminant Vaccines Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Ruminant Vaccines Revenue Market Share by Region (2024-2024)
Table 23. Global Ruminant Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Ruminant Vaccines Revenue Market Share by Region (2024-2034)
Table 25. North America Ruminant Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Ruminant Vaccines Sales by Country (2024-2024) & (K Units)
Table 27. North America Ruminant Vaccines Sales by Country (2024-2034) & (K Units)
Table 28. North America Ruminant Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Ruminant Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Ruminant Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Ruminant Vaccines Sales by Country (2024-2024) & (K Units)
Table 32. Europe Ruminant Vaccines Sales by Country (2024-2034) & (K Units)
Table 33. Europe Ruminant Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Ruminant Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Ruminant Vaccines Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Ruminant Vaccines Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Ruminant Vaccines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Ruminant Vaccines Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Ruminant Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Ruminant Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Ruminant Vaccines Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Ruminant Vaccines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Ruminant Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Ruminant Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Ruminant Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Ruminant Vaccines Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Ruminant Vaccines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Ruminant Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Ruminant Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Ruminant Vaccines Sales (K Units) by Type (2024-2024)
Table 51. Global Ruminant Vaccines Sales (K Units) by Type (2024-2034)
Table 52. Global Ruminant Vaccines Sales Market Share by Type (2024-2024)
Table 53. Global Ruminant Vaccines Sales Market Share by Type (2024-2034)
Table 54. Global Ruminant Vaccines Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Ruminant Vaccines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Ruminant Vaccines Revenue Market Share by Type (2024-2024)
Table 57. Global Ruminant Vaccines Revenue Market Share by Type (2024-2034)
Table 58. Global Ruminant Vaccines Price (US$/Unit) by Type (2024-2024)
Table 59. Global Ruminant Vaccines Price (US$/Unit) by Type (2024-2034)
Table 60. Global Ruminant Vaccines Sales (K Units) by Application (2024-2024)
Table 61. Global Ruminant Vaccines Sales (K Units) by Application (2024-2034)
Table 62. Global Ruminant Vaccines Sales Market Share by Application (2024-2024)
Table 63. Global Ruminant Vaccines Sales Market Share by Application (2024-2034)
Table 64. Global Ruminant Vaccines Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Ruminant Vaccines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Ruminant Vaccines Revenue Market Share by Application (2024-2024)
Table 67. Global Ruminant Vaccines Revenue Market Share by Application (2024-2034)
Table 68. Global Ruminant Vaccines Price (US$/Unit) by Application (2024-2024)
Table 69. Global Ruminant Vaccines Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck Ruminant Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Zoetis Ruminant Vaccines Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Boehringer Ingelheim Ruminant Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Ceva Ruminant Vaccines Product
Table 89. Ceva Recent Developments/Updates
Table 90. CAHIC Corporation Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. CAHIC Ruminant Vaccines Product
Table 94. CAHIC Recent Developments/Updates
Table 95. HVRI Corporation Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. HVRI Ruminant Vaccines Product
Table 99. HVRI Recent Developments/Updates
Table 100. Ringpu Biology Corporation Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Ringpu Biology Ruminant Vaccines Product
Table 104. Ringpu Biology Recent Developments/Updates
Table 105. Yebio Corporation Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Yebio Ruminant Vaccines Product
Table 109. Yebio Recent Developments/Updates
Table 110. DHN Corporation Information
Table 111. DHN Description and Business Overview
Table 112. DHN Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. DHN Ruminant Vaccines Product
Table 114. DHN Recent Developments/Updates
Table 115. WINSUN Corporation Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. WINSUN Ruminant Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Elanco Corporation Information
Table 121. Elanco Description and Business Overview
Table 122. Elanco Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Elanco Ruminant Vaccines Product
Table 124. Elanco Recent Developments/Updates
Table 125. Virbac Corporation Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Virbac Ruminant Vaccines Product
Table 129. Virbac Recent Developments/Updates
Table 130. Jinyu Bio-Technology Corporation Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Jinyu Bio-Technology Ruminant Vaccines Product
Table 134. Jinyu Bio-Technology Recent Developments/Updates
Table 135. ChengDu Tecbond Corporation Information
Table 136. ChengDu Tecbond Description and Business Overview
Table 137. ChengDu Tecbond Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. ChengDu Tecbond Ruminant Vaccines Product
Table 139. ChengDu Tecbond Recent Developments/Updates
Table 140. CAVAC Corporation Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. CAVAC Ruminant Vaccines Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Kyoto Biken Laboratories Corporation Information
Table 146. Kyoto Biken Laboratories Description and Business Overview
Table 147. Kyoto Biken Laboratories Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Kyoto Biken Laboratories Ruminant Vaccines Product
Table 149. Kyoto Biken Laboratories Recent Developments/Updates
Table 150. FATRO Corporation Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. FATRO Ruminant Vaccines Product
Table 154. FATRO Recent Developments/Updates
Table 155. Vaksindo Corporation Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Vaksindo Ruminant Vaccines Product
Table 159. Vaksindo Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Ruminant Vaccines Distributors List
Table 163. Ruminant Vaccines Customers List
Table 164. Ruminant Vaccines Market Trends
Table 165. Ruminant Vaccines Market Drivers
Table 166. Ruminant Vaccines Market Challenges
Table 167. Ruminant Vaccines Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ruminant Vaccines
Figure 2. Global Ruminant Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ruminant Vaccines Market Share by Type in 2022 & 2034
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Ruminant Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Ruminant Vaccines Market Share by Application in 2022 & 2034
Figure 9. Cattle
Figure 10. Sheep
Figure 11. Other
Figure 12. Global Ruminant Vaccines Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Ruminant Vaccines Market Size (2024-2034) & (US$ Million)
Figure 14. Global Ruminant Vaccines Sales (2024-2034) & (K Units)
Figure 15. Global Ruminant Vaccines Average Price (US$/Unit) & (2024-2034)
Figure 16. Ruminant Vaccines Report Years Considered
Figure 17. Ruminant Vaccines Sales Share by Manufacturers in 2022
Figure 18. Global Ruminant Vaccines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Ruminant Vaccines Players: Market Share by Revenue in 2022
Figure 20. Ruminant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Ruminant Vaccines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Ruminant Vaccines Sales Market Share by Country (2024-2034)
Figure 23. North America Ruminant Vaccines Revenue Market Share by Country (2024-2034)
Figure 24. United States Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Ruminant Vaccines Sales Market Share by Country (2024-2034)
Figure 27. Europe Ruminant Vaccines Revenue Market Share by Country (2024-2034)
Figure 28. Germany Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Ruminant Vaccines Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Ruminant Vaccines Revenue Market Share by Region (2024-2034)
Figure 35. China Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Ruminant Vaccines Sales Market Share by Country (2024-2034)
Figure 43. Latin America Ruminant Vaccines Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Ruminant Vaccines Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Ruminant Vaccines Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Ruminant Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Ruminant Vaccines by Type (2024-2034)
Figure 53. Global Revenue Market Share of Ruminant Vaccines by Type (2024-2034)
Figure 54. Global Ruminant Vaccines Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Ruminant Vaccines by Application (2024-2034)
Figure 56. Global Revenue Market Share of Ruminant Vaccines by Application (2024-2034)
Figure 57. Global Ruminant Vaccines Price (US$/Unit) by Application (2024-2034)
Figure 58. Ruminant Vaccines Value Chain
Figure 59. Ruminant Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed